A Phase II, Randomized, Double-blind, Placebo-controlled, Parallel Group Proof-of-Concept Trial to Assess Relief of Meal Induced Heartburn by a Combination of Lansoprazole 15 mg and Antacid Versus Lansoprazole 15 mg and Antacid (Calcium Carbonate and Magnesium Hydroxide) Alone.
Phase of Trial: Phase II
Latest Information Update: 25 Mar 2011
At a glance
- Drugs Calcium carbonate; Lansoprazole; Magnesium hydroxide
- Indications Heartburn
- Focus Therapeutic Use
- Sponsors Novartis
- 27 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Feb 2010 Actual end date (January 2010) added as reported by ClinicalTrials.gov.
- 31 Dec 2009 New trial record